Syfovre Alternatives Compared
| Syfovre (pegcetacoplan) | Izervay (avacincaptad pegol) | Pegcetacoplan ophthalmic |
|
|---|
| Syfovre (pegcetacoplan) | Izervay (avacincaptad pegol) | Pegcetacoplan ophthalmic |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Geographic Atrophy, Macular Degeneration. Syfovre may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Macular Degeneration, Geographic Atrophy. Izervay may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Geographic Atrophy, Macular Degeneration. Pegcetacoplan ophthalmic may also be used for purposes not listed in this medication guide. |
Related suggestions Macular Degeneration
Geographic Atrophy
|
|||||||||||||||
| More about Syfovre (pegcetacoplan) | More about Izervay (avacincaptad pegol) | More about Pegcetacoplan ophthalmic | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Syfovre has an average rating of 8.2 out of 10 from a total of 6 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 17% reported a negative effect. |
Izervay has an average rating of 9.0 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Pegcetacoplan ophthalmic has an average rating of 8.2 out of 10 from a total of 6 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Syfovre side effects |
View all Izervay side effects |
|||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Syfovre prices |
View all Izervay prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
N/A |
Syfovre | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
108 hours |
288 hours |
108 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 2 drugs are known to interact with Syfovre:
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 2 drugs are known to interact with Pegcetacoplan ophthalmic:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.